ATUAÇAO DA ACUPUNTURA SISTÊMICA NA MELHORA DA DOENÇA PULMONAR OBSTRUTIVA CRÔNICA – REVISÃO SISTEMÁTICA

Introducao: A Doenca Pulmonar Obstrutiva Cronica (DPOC) e uma doenca respiratoria com  obstrucao cronica ao fluxo aereo. A Medicina Tradicional Chinesa (MTC) e uma medicina complementar, e a Acupuntura Sistemica e eficaz em seu tratamento. Objetivo: Analisar pela revisao sistematica a eficacia da Acupuntura Sistemica nos sintomas respiratorios, funcao pulmonar e qualidade de vida na DPOC. Metodologia: Revisao sistematica em artigos indexados no periodo de 2010 a 2020, nas bases de dados Scielo, Pubmed, Pedro, Biblioteca Virtual da Saude e Chrocrane. Palavras chaves: Acupuncture e COPD. Resultados: Nas bases de dados Pubmed e Pedro foram encontrados 38 artigos, e apos a leitura 32 artigos foram excluidos, totalizando 5 artigos inclusos. Consideracoes finais: A Acupuntura Sistemica se mostrou eficaz para o controle e tratamento da dispneia, melhoras em funcao pulmonar (VEF1 e CVF), em oxigenacao durante o TC6M e qualidade de vida. THE ROLE OF SYSTEMIC ACUPUNCTURE IN THE IMPROVEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE - SYSTEMATIC REVIEW Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a respiratory disease where there is a chronic obstruction to the airflow. Traditional Chinese Medicine (TCM) as a complementary medicine benefits health and is effective in its treatment, with the use of Systemic Acupuncture. Objective: To analyze, through a systematic review, the effectiveness of Systemic Acupuncture in respiratory symptoms, lung function and quality of life in COPD. Methodology: systematic review of articles indexed from 2010 to 2020, in the Scielo, Pubmed, Pedro, Virtual Health Library and Chrocrane databases. Keywords: Acupuncture and COPD. Results: In the Pubmed and Pedro databases, 38 articles were found, and after reading 32 articles were excluded, totaling 5 articles included. Final considerations: Systemic acupuncture proved to be effective for the control and treatment of dyspnea in patients with COPD, improvements in pulmonary function (FEV1 and FVC) and in oxygenation during the 6MWT and in quality of life.